ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,529Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 403

$1.06M Total Retail Price of All Prescriptions

Rank: 4 out of 403

398 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
81% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 398 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

6% of this provider’s 398 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

2% of this provider’s 11,187 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 28%.

Prescription Price

$73 was the average price of a prescription from this provider, compared to $72 among peers.

Prescriptions per Patient

37 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
LEVOTHYROXINE SODIUM 473 399 1 3
WARFARIN SODIUM 466 422 2 12
METOPROLOL TARTRATE 442 420 3 10
LISINOPRIL 392 343 4 1
FUROSEMIDE 363 313 5 7
RISPERIDONE 251 153 6 48
SIMVASTATIN 249 213 7 2
OMEPRAZOLE 239 208 8 9
PRAVASTATIN SODIUM 232 160 9 14
TRAZODONE HCL 221 178 10 25
METFORMIN HCL 221 174 10 8
GABAPENTIN 214 159 12 17
AMLODIPINE BESYLATE 204 173 13 4
ATORVASTATIN CALCIUM 202 176 14 5
DONEPEZIL HCL 187 161 15 23
ESCITALOPRAM OXALATE 186 149 16 36
HYDROCHLOROTHIAZIDE 166 158 17 6
MIRTAZAPINE 161 133 18 38
DIOVAN 149 107 19 24
ZETIA 146 128 20 59
OXYCONTIN 144 37 S2 21 63
METOPROLOL SUCCINATE 143 116 22 11
CYMBALTA 138 95 23 43
TRAMADOL HCL 137 129 24 28
ATENOLOL 134 134 25 13
NAMENDA 133 114 26 41
SERTRALINE HCL 131 116 27 20
CITALOPRAM HBR 128 111 28 22
OXYCODONE HCL 110 23 S2 29 39
QUETIAPINE FUMARATE 110 90 29 52
TAMSULOSIN HCL 107 106 31 27
CRESTOR 107 69 31 19
HYDROCODONE-ACETAMINOPHEN 107 62 S3 31 15
NEXIUM 107 57 31 18
LANTUS 99 83 35 54
SPIRIVA 95 83 36 35
CARVEDILOL 91 84 37 32
TOPIRAMATE 91 17 37 125
POTASSIUM CHLORIDE 90 89 39 37
GLIPIZIDE 89 75 40 70
KLOR-CON M20 83 57 41 85
PAROXETINE HCL 83 49 41 68
OXYCODONE-ACETAMINOPHEN 81 70 S2 43 45
CYCLOBENZAPRINE HCL 80 13 R 44 91
OLANZAPINE 80 58 44 77
BACLOFEN 78 34 46 110
ACTOS 76 59 47 95
DIGOXIN 76 76 47 56
ISOSORBIDE MONONITRATE ER 75 75 49 62
FLUTICASONE PROPIONATE 74 65 50 47
LOSARTAN POTASSIUM 73 70 51 21
IPRATROPIUM-ALBUTEROL 67 65 52 120
FAMOTIDINE 67 47 52 73
LAMOTRIGINE 66 66 54 168
MORPHINE SULFATE ER 66 0 S2 54 104
LIDODERM 66 64 54 74
ADVAIR DISKUS 62 56 57 33
PANTOPRAZOLE SODIUM 62 47 57 30
ZOLPIDEM TARTRATE 61 57 59 16
ALBUTEROL SULFATE 60 57 60 196
ALENDRONATE SODIUM 60 30 60 26
NIASPAN 58 22 62 142
FENTANYL 57 43 S2 63 71
CLOPIDOGREL 55 55 64 55
CARBIDOPA-LEVODOPA 53 43 65 78
PREDNISONE 51 43 66 34
HUMALOG 50 43 67 151
LEVEMIR FLEXPEN 50 43 67 121
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.